A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
Clinical trial NCT02614287 · COMPLETED
Trial details
- NCT number
- NCT02614287
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2017-05-12
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.